Predictors of survival and cause of death in patients with essential thrombocythemia

被引:14
作者
Lekovic, Danijela [1 ]
Gotic, Mirjana [1 ,2 ]
Sefer, Dijana [1 ]
Mitrovic-Ajtic, Olivera [3 ]
Cokic, Vladan [3 ]
Milic, Natasa [2 ,4 ]
机构
[1] Clin Ctr Serbia, Clin Hematol, Belgrade 11000, Serbia
[2] Univ Belgrade, Fac Med, Belgrade, Serbia
[3] Univ Belgrade, Inst Med Res, Belgrade, Serbia
[4] Univ Belgrade, Inst Med Stat, Belgrade, Serbia
关键词
myeloproliferative neoplasms; essential thrombocythemia; cardiovascular risk factors; prognosis; survival; DEFINED ESSENTIAL THROMBOCYTHEMIA; PROGNOSTIC-FACTORS; LIFE EXPECTANCY; MYELODYSPLASTIC SYNDROME; PRIMARY MYELOFIBROSIS; RISK STRATIFICATION; POLYCYTHEMIA-VERA; CANCER-PATIENTS; COMORBIDITY; THROMBOSIS;
D O I
10.1111/ejh.12517
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
ObjectivesStandard risk stratification for overall survival (OS) in patients with essential thrombocythemia (ET) is based on advanced age and history of thrombotic events. Recently, International Prognostic Score for ET (IPSET) incorporated also leukocytosis in prognostic model. The aim of this study was to establish additional risk factors for OS in ET patients. MethodsAfter the median follow-up of 7yr, in 244 consecutive ET patients, 32 deaths were documented (13.2%). The 5- and 10-yr OS was 95.9% and 79.7%, respectively. Considered additional risk factors at diagnosis of ET were the presence of arterial hypertension, diabetes, hyperlipidemia, and smoking attitude. ResultsThe main cause of death in 75% of patients was cardiovascular (CV) comorbidity. Patients with CV risk factors had increased risk of death (HR=2.33). Cox regression model identified age, leukocytosis, presence of CV risk factors, and previous thrombosis as unfavorable predictors of survival. Based on these parameters, four risk groups were defined, with significantly different survivals (P<0.001). Improved prognostic model displayed a better hazard ratio profile compared to the standard risk stratification and IPSET. ConclusionThe addition of CV risk factors allows better prognostic assessment by delineating the intermediate-risk category and improved identification of the high-risk patients.
引用
收藏
页码:461 / 466
页数:6
相关论文
共 37 条
[1]   The impact of co-morbidity on life expectancy among men with localized prostate cancer [J].
Albertsen, PC ;
Fryback, DG ;
Storer, BE ;
Kolon, TF ;
Fine, J .
JOURNAL OF UROLOGY, 1996, 156 (01) :127-132
[2]   Development and validation of an International Prognostic Score of thrombosis in World Health Organization-essential thrombocythemia (IPSET-thrombosis) [J].
Barbui, Tiziano ;
Finazzi, Guido ;
Carobbio, Alessandra ;
Thiele, Juergen ;
Passamonti, Francesco ;
Rumi, Elisa ;
Ruggeri, Marco ;
Rodeghiero, Francesco ;
Randi, Maria Luigia ;
Bertozzi, Irene ;
Gisslinger, Heinz ;
Buxhofer-Ausch, Veronika ;
De Stefano, Valerio ;
Betti, Silvia ;
Rambaldi, Alessandro ;
Vannucchi, Alessandro M. ;
Tefferi, Ayalew .
BLOOD, 2012, 120 (26) :5128-5133
[3]   Survival and Disease Progression in Essential Thrombocythemia Are Significantly Influenced by Accurate Morphologic Diagnosis: An International Study [J].
Barbui, Tiziano ;
Thiele, Juergen ;
Passamonti, Francesco ;
Rumi, Elisa ;
Boveri, Emanuela ;
Ruggeri, Marco ;
Rodeghiero, Francesco ;
d'Amore, Emanuele S. G. ;
Randi, Maria Luigia ;
Bertozzi, Irene ;
Marino, Filippo ;
Vannucchi, Alessandro M. ;
Antonioli, Elisabetta ;
Carrai, Valentina ;
Gisslinger, Heinz ;
Buxhofer-Ausch, Veronika ;
Muellauer, Leonhard ;
Carobbio, Alessandra ;
Gianatti, Andrea ;
Gangat, Naseema ;
Hanson, Curtis A. ;
Tefferi, Ayalew .
JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (23) :3179-3184
[4]   Prevention of chronic disease in the 21st century: elimination of the leading preventable causes of premature death and disability in the USA [J].
Bauer, Ursula E. ;
Briss, Peter A. ;
Goodman, Richard A. ;
Bowman, Barbara A. .
LANCET, 2014, 384 (9937) :45-52
[5]  
Buttar Harpal S, 2005, Exp Clin Cardiol, V10, P229
[6]   Risk factors for arterial and venous thrombosis in WHO-defined essential thrombocythemia: an international study of 891 patients [J].
Carobbio, Alessandra ;
Thiele, Juergen ;
Passamonti, Francesco ;
Rumi, Elisa ;
Ruggeri, Marco ;
Rodeghiero, Francesco ;
Randi, Maria Luigia ;
Bertozzi, Irene ;
Vannucchi, Alessandro M. ;
Antonioli, Elisabetta ;
Gisslinger, Heinz ;
Buxhofer-Ausch, Veronika ;
Finazzi, Guido ;
Gangat, Naseema ;
Tefferi, Ayalew ;
Barbui, Tiziano .
BLOOD, 2011, 117 (22) :5857-5859
[7]   Life expectancy and prognostic factors in the classic BCR/ABL-negative myeloproliferative disorders [J].
Cervantes, F. ;
Passamonti, F. ;
Barosi, G. .
LEUKEMIA, 2008, 22 (05) :905-914
[8]   Long-term outcome of 231 patients with essential thrombocythemia - Prognostic factors for thrombosis, bleeding, myelofibrosis, and leukemia [J].
Chim, CS ;
Kwong, YL ;
Lie, AKW ;
Ma, SK ;
Chan, CC ;
Wong, LG ;
Kho, BCS ;
Lee, HK ;
Sim, JPY ;
Chan, CHN ;
Chan, JCW ;
Yeung, YM ;
Law, M ;
Liang, R .
ARCHIVES OF INTERNAL MEDICINE, 2005, 165 (22) :2651-2658
[9]   Worldwide epidemic of hypertension [J].
Chockalingam, Arun ;
Campbell, Norman R. ;
Fodor, J. George .
CANADIAN JOURNAL OF CARDIOLOGY, 2006, 22 (07) :553-555
[10]   Impact of comorbidities by ACE-27 in the revised-IPSS for patients with myelodysplastic syndromes [J].
Daver, Naval ;
Naqvi, Kiran ;
Jabbour, Elias ;
Kadia, Tapan ;
DiNardo, Courtney ;
Cardenas-Turanzas, Marylou ;
Pierce, Sherry ;
Khanh Thi-Thuy Nguyen ;
Bueso-Ramos, Carlos ;
Kantarjian, Hagop ;
Garcia-Manero, Guillermo .
AMERICAN JOURNAL OF HEMATOLOGY, 2014, 89 (05) :509-516